Safety and efficacy of remazolam toluene sulfonate in sedation of mechanical ventilation patients in intensive care department

Safety and efficacy of remazolam toluene sulfonate in sedation of mechanical ventilation patients in intensive care department - RT-SMV

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058409

Enrollment

Unknown

Registered

2022-04-09

Start date

2022-04-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with mechanical ventilation

Interventions

Intervention group:Remazolam toluene sulfonate

Control group:Propofol

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Estimated receive mechanical ventilation equal or more than 24 hours.

Exclusion criteria

Exclusion criteria: 1. Patients or family members do not agree to be enrolled.

Design outcomes

Primary

Measure	Time frame
Light sedation;	—

Secondary

Measure	Time frame
Level of cytokines;	—

Countries

China

Contacts

Public ContactXue-Zhong Xing

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

xingxuezhong@cicams.ac.cn+86 1087788257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026